The discovery of microRNAs (miRNAs) is one of the major scientific breakthroughs in recent years and has revolutionized the way we look at gene regulation.
<h3>
What is MicroRNAs ?</h3>
microRNA is the name of a family of molecules that helps cells control the kinds and amounts of proteins they make
- That is, cells use microRNA to help control gene expression. Molecules of microRNA are found in cells and in the bloodstream.
- The miRNA functions as a guide by base-pairing with target mRNA to negatively regulate its expression.
Learn more about MicroRNAs here:
brainly.com/question/24885193
#SPJ4
The preponderance of the evidence, however, indicates that Eric Harris was a disturbed young man who had other motivation for the attack than retaliation for harassment.
Answer:
The dermis is the second layer of the skin that protects the human body from stress and strain. It is found between the epidermis and the hypodermis or the subcutaneous tissues.
The dermis layer is composed of two layers: papillary dermis and reticular dermis.
The reticular dermis is the thick layer of the dermis, composed of the dense irregular connective tissues. It contains of elastic protein fibers that makes the skin stretchable and elastic (able to rebound).
<u>Therefore, the reticular dermis makes the skin stretchable and elastic (able to rebound).</u>
In the intervention group, 212 women (5.7 per 10,000 person-years) and 176 (4.7 per 10,000 person-years) received an ovarian cancer diagnosis (rate ratio [RR], 1.21; 95% confidence interval [CI], 0.99-1.48).
In the intervention group, there were 118 ovarian cancer-related deaths (3.1 per 10,000 person-years), compared to 100 in the standard care group (mortality RR, 1.18; 95% CI, 0.82-1.71).
1080 of the 3285 women who had false-positive test results underwent surgical follow-up, and 163 of them (15%) had at least one significant consequence.
Except for ovarian, colorectal, and lung cancer, there were 2924 deaths from other causes (76.6 per 10 000 person-years) in the intervention group and 2914 deaths (76.2 per 10 000 person-years)
Simultaneous screening with CA-125 and transvaginal ultrasound in comparison to standard treatment did not lower ovarian cancer mortality among women in the general US population. Complications were linked to diagnostic examination after a false-positive screening test result.
To learn more about ovarian cancer here:-
brainly.com/question/25637266?referrer=searchResults
#SPJ4
